| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| TOOKER ADIN M | President | ONE HARTFORD PLAZA, HARTFORD | Anthony J. Salerno, Jr., Attorney-in-Fact | 2025-05-19 | 0001953211 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Common Stock | Options Exercise | $447K | +8.31K | +26.19% | $53.81 | 40K | May 15, 2025 | Direct | |
| transaction | HIG | Common Stock | Options Exercise | $299K | +6.86K | +17.15% | $43.59 | 46.9K | May 15, 2025 | Direct | |
| transaction | HIG | Common Stock | Options Exercise | $329K | +6.73K | +14.35% | $48.89 | 53.6K | May 15, 2025 | Direct | |
| transaction | HIG | Common Stock | Sale | -$410K | -3.17K | -5.91% | $129.28 | 50.5K | May 15, 2025 | Direct | F1, F2 |
| transaction | HIG | Common Stock | Sale | -$424K | -3.28K | -6.5% | $129.28 | 47.2K | May 15, 2025 | Direct | F1, F3 |
| transaction | HIG | Common Stock | Sale | -$456K | -3.56K | -7.55% | $128.02 | 43.6K | May 15, 2025 | Direct | F1, F4 |
| transaction | HIG | Common Stock | Sale | -$459K | -3.58K | -8.22% | $128.00 | 40K | May 15, 2025 | Direct | F1, F5 |
| transaction | HIG | Common Stock | Sale | -$518K | -4.01K | -10.01% | $129.26 | 36K | May 15, 2025 | Direct | F1, F6 |
| transaction | HIG | Common Stock | Sale | -$551K | -4.3K | -11.94% | $128.01 | 31.7K | May 15, 2025 | Direct | F1, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Stock Option | Options Exercise | $0 | -8.31K | -33.34% | $0.00 | 16.6K | May 15, 2025 | Common Stock | 8.31K | $53.81 | Direct | F8 |
| transaction | HIG | Stock Option | Options Exercise | $0 | -6.73K | -50% | $0.00 | 6.73K | May 15, 2025 | Common Stock | 6.73K | $48.89 | Direct | F9 |
| transaction | HIG | Stock Option | Options Exercise | $0 | -6.86K | -100% | $0.00 | 0 | May 15, 2025 | Common Stock | 6.86K | $43.59 | Direct | F10 |
| holding | HIG | Stock Option | 26.7K | May 15, 2025 | Common Stock | 26.7K | $49.01 | Direct | F11 | |||||
| holding | HIG | Stock Option | 25.2K | May 15, 2025 | Common Stock | 25.2K | $51.87 | Direct | F12 | |||||
| holding | HIG | Stock Option | 24.1K | May 15, 2025 | Common Stock | 24.1K | $55.27 | Direct | F13 | |||||
| holding | HIG | Stock Option | 24.2K | May 15, 2025 | Common Stock | 24.2K | $69.41 | Direct | F14 | |||||
| holding | HIG | Stock Option | 24.3K | May 15, 2025 | Common Stock | 24.3K | $78.28 | Direct | F15 | |||||
| holding | HIG | Stock Option | 16.5K | May 15, 2025 | Common Stock | 16.5K | $95.74 | Direct | F16 | |||||
| holding | HIG | Stock Option | 25.5K | May 15, 2025 | Common Stock | 25.5K | $116.41 | Direct | F17 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 14, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| F2 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.69 - $129.63 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.65 - $129.60 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.61 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.52 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.68 - $129.64 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.67 - $128.65 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F8 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
| F9 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
| F10 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
| F11 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
| F12 | The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
| F13 | The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
| F14 | The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. |
| F15 | One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
| F16 | One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |
| F17 | One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date. |